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A Formal Total Synthesis of Deoxynojirimycin from D-Glucitol
Raquel M. Braga*  and Lucilia Kato
Instituto de Química, Universidade Estadual de Campinas, CP 6154, 13084-971 Campinas - SP, Brazil
Descrevemos a síntese formal da desoxinojirimicina usando D-glucitol como material de partida
economicamente atraente. Através de uma seqüência de reações de proteção e desproteção seletivas
e reações de substituição nucleofílica obtivemos diversos intermediários isopropilidênicos. A formação
de um epóxido intermediário e sua subseqüente abertura, através de uma reação nucleofílica
intramolecular, levou à obtenção do heterociclo 1,5-didesoxi-1,5-diamino-2,3-O-isopropilideno-6-
silila-D-glucitol, que é um precursor da desoxinojirimicina (DNJ).
This report deals with the formal synthesis of deoxynojirimycin using D-glucitol as an inexpensive
starting material. Through a sequence of several selective protection/deprotection and nucleophilic
substitution reactions, many isopropylidene derivatives were obtained. Formation of an epoxide
intermediate and its subsequent ring opening, via intramolecular nucleophilic substitution, leads to
the synthesis of heterocyclic 1,5-dideoxy-1,5-diamine-2,3-O-isopropylidene-6-silyl-D-glucitol,
which is a precursor of deoxynojirimycin (DNJ).
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Introduction
Imino sugars,1  sometimes called azasugars, are
compounds that have been shown to selectively inhibit
oligosaccharide processing enzymes (i.e., glycosidases or
glycotransferases).2-5  Because of the potential
chemotherapeutic applications of such compounds, there
is a continuing interest on the synthesis of imino sugars.
Deoxynojirimycin (DNJ, 1,5-dideoxy-1,5-imino-D-
glucitol) is an inhibitor for several glycosidases, and,
additionally, it shows antidiabetic and antiviral activities,
including anti-HIV activity.6-8  Its importance is disclosed
by the large number of publications devoted to its
preparation.
After Paulsen et al.9  have obtained 1- deoxynojirimycin
and disclosed its potent glucosidase inhibitor effects, it
has been synthesized by a variety of methods. Kinast et
al.10  obtained 1- deoxynojirimycin in four steps from
D-glucose through an enzymatic oxidation. Behling et
al.11  described a synthesis of DNJ (1) from L-sorbose that
requires the isolation of only two intermediates and the
use of only one protection/deprotection protocol. Setoi et
al.12-14 described a synthesis of DNJ (1) from D-mannose
by a multi-step approach with protecting/deprotecting
group manipulation. To date several syntheses of DNJ (1)
and analogues have been described.7,15-18
This report deals with the formal total synthesis of DNJ
(1) using D-glucitol, an inexpensive starting material,
through a sequence of several selective protection/
deprotection and nucleophilic substitution reactions.19
Results and Discussion
Treatment of D-glucitol with THF, 2,2-dimethoxy-
propane (DMP) and p-toluenesulfonic acid (TsOH) resulted
in diacetonides 4 (3%), 3 (46%) and triacetonide 2 (16%),
as shown in Scheme 1.
The 4-O-acetyl-1-azido-1-deoxy-2,3:5,6-di-O-
isopropylidene-D-glucitol (7) was obtained from 3 in 37%
overall yield by the sequence of sulfonylation, acetylation
and azidation (3 → 5a → 6 → 7). Selective cleavage of the
terminal acetonide group was accomplished using
p-toluenesulfonic acid in methanol at 0 oC for 5 h. The
resulting mixture of acetonides 7 (51%) and 8a (34%) was
purified by flash column chromatography. Under the
applied conditions, acyl group migration from C-4 to C-6
was observed. Acyl group migration in non-acidic aqueous
media or in dichloromethane containing triethylamine was
also observed by Kilonda et al.6 When this reaction is
carried out using pyridinium 4-toluenesulfonate as catalyst,
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acyl group migration is not observed. This migration
protects the primary group at C-6 from tosylation during
the next step. The azide epoxide 10 was obtained after
sulfonation of 8a and treatment with K2CO3, followed by
basic treatment to promote deacetylation. The trans
stereochemistry of the resulting epoxide 10 is confirmed
by the coupling constant (J 2.2 Hz) between H4 and H5.20,21
The intermediate 11 is obtained by protection with
TBDMSCl. Treatment of the epoxide azide 11 with NaBH4
in boiling methanol gave 13 a protected form of DNJ (1).
The intermediate epoxide amine 12 could not be isolated
(Scheme 1) and this reaction afforded a single piperidine
heterocycle. In summary, 13 was obtained in 9 steps and
0.4% overall yield from D-glucitol.
Setoi et al.12-14 have obtained DNJ (1) by treatment of
13 a protected form of DNJ (1) with aqueous TFA for 12 h,
which has been prepared from D-mannose in 14 steps and
0.4% overall yield.
1H NMR, 13C NMR, 2D proton-proton homocorrelated
and C-H heterocorrelated spectra and comparation with
literature data confirmed the structure of intermediates.21
Scheme 1.
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Experimental
General procedures
Thin-layer chromatography (TLC) was carried out on
plates precoated with silica gel 60 F254 (E. Merck).
Detection was by UV at 254 nm, followed by charring
with a solution of ammoniun molybdate or Dragendorff
reagent.22  Column chromatography was carried out on
silica gel (230-400 mesh) and, unless otherwise stated,
mixtures of heptane-EtOAc or CH2Cl2-MeOH were used as
eluent. All reactions were conducted under an argon
atmosphere. Anhydrous Na2SO4 was used to dry organic
solution and the removal of the solvent was done under
vacuum with a rotary evaporator. Solvents were dried and
purified using standard methods.23  IR spectra were
recorded with a Bomen FTIR spectrometer using KBr
pellets or NaCl cells. Elemental analyses were performed
on a model 2400 CHN-Perkin Elmer instrument. Nuclear
magnetic resonance spectra were obtained using Varian
300 MHz or Bruker AC-300 MHz spectrometers in CDCl3
solutions with (CH3)4Si as internal reference (300 MHz for
1H and 75 MHz for 13C). The assignments were confirmed
by proton-proton homocorrelated and carbon-proton
heterocorrelated spectra. HREIMS (70 eV, direct probe)
experiment was performed using a VG Auto Spec-Fisions
Instrument using electron ionisation at 70 eV (linked scan
from 8 keV collisions with helium). Optical rotations were
measured with a Jasco model J-720 digital polarimeter.
1,2:5,6-di-O-isopropylidene-D-glucitol (4), 2,3:5,6-di-O-
isopropylidene-D-glucitol (3) and 1,2:3,4:5,6-tri-O-
isopropylidene-D-glucitol (2)
To a mixture containing 3 cm3 of THF and 1.03 g (5.7
mmol) of D-glucitol, 1.5 cm3 of DMP and TsOH were added.
The mixture was stirred at 0 oC for 1 h and left to stand at
room temperature for 12 h. The mixture was neutralized
with aqueous NH3 and evaporated. The residue was
dissolved in CH2Cl2 and the solution was washed with
saturated aqueous NaCl and dried over anhydrous Na2SO4.
Purification by column chromatography gave three
derivatives: 4 (0.04 g, 3%); 3 (0.667 g, 46%) and 2 (0.271 g,
16%).
2. Yellowish amorphous solid; [α]D25 = +7.61° (CHCl3);
(lit.24,25  +7.5°), ν
max.
/cm-1: 2986,1370, 1073 (film); 1H NMR
(CDCl3) δ 1.34 (s, 3H, CH3), 1.38 (s, 3H, CH3), 1.39 (s , 3H,
CH3), 1.42 (s , 3H, CH3), 1.43 (s, 3H, CH3), 1.44 (s, 3H,
CH3), 3.85 (dd, J 8.0 and 7.3 Hz, 1H, H-1), 3.97 (dd, J 8.0
and 4.7 Hz, 1H, H-1’), 4.04 (dd, J 8.3 and 6.7Hz, 1H, H-6),
4.00-4.20 (m, 4H, H-2, H-3, H-4 and H-5), 4.15 (dd, J 8.3
and J 2.3 Hz, 1H, H-6). 13C NMR (CDCl3) δ: 25.3, 26.6,
25.7, 26.3, 26.9, 27.2, 66.1, 67.9, 76.8, 77.3, 78.1, 80.5,
109.5, 109.8, 109.8. Elem. Anal: Calc. for C15H26O6: C,
59.60; H, 8.61; Found: C, 60.08; H, 8.70.
4. Colorless needles; mp 90 oC, [α]D25= +10.74°
(CHCl3); 1H NMR (CDCl3) δ 1.35 (s, 3H, CH3), 1.38 (s, 3H,
CH3), 1.41 (s, 3H, CH3), 1.45 (s, 3H, CH3), 2.65 (br, s, 1H,
OH), 2.83 (br ,s, 1 H, OH), 3.52 (s, 1H, H-3), 3.75 (dt, J 4.7
and 1.4 Hz,1 H, H-4), 3.91 (dd, J 8.4 and 7.0 Hz, 1H, H-6),
4.02 (dd, J 7.5 and 4.7 Hz, 1H, H-1’), 4.09 (dd, J 8.4 and 6.6
Hz, 1H, H-6
‘
), 4.10-4.20 (m, 2H, H-1, H-2), 4.28 (dt, J 7.0,
6.6 and 4.2 Hz, 1 H, H-5); 1H NMR (CDCl3/TMS/D2O) δ
1.35 (s, 3H, CH3), 1.38 (s, 3H, CH3), 1.41 (s, 3H, CH3), 1.45
(s, 3H, CH3), 3.51 (dd, J 7.5 and 1.4 Hz, 1H, H-3), 3.75 (dd,
J 4.7 and 1.4 Hz, 1 H, H-4), 3.90 (dd, J 8.4 and 7.0Hz,1H,
H-6), 4.02 (dd, J 7.5 and 4.7Hz, 1H, H-1’), 4.08 (dd, 8.4 and
6.6Hz, 1H, H-6‘), 4.15 (m, 2H, H-1, H-2), 4.28 (dt, J 7.0, 6.6
and 4.7 Hz, 1 H, H-5); 13C NMR (CDCl3) δ: 25.3, 25.4, 26.5,
26.9, 66.1, 67.2, 69.4, 73.9, 75.3, 78.1, 109.5, 110.0.; Anal.
Calc. for C, 54.96; H, 08.83; Found: C, 54.93; H, 08.46.
3. Colorless oil; [α]D25 = -12.43° (CHCl3); (lit.24,25
-15.15°). 1H NMR (CDCl3): δ 1.35 (s, 3H, CH3), 1.41 (s, 3H,
CH3), 1.43 (s, 6H, 2 CH3), 2.60 (m, 2H, 2 OH), 3.50 (dt, J 2.5
and 6.6 Hz, 1H, H-4), 3.71 (m, 1H, H-1), 3.81 (m, 1H, H-1´),
4.00-4.20 (m, 5H, H-2,
 
H-3, H-5, H-6 and H-6‘). 1H NMR
(CDCl3//D2O) δ: 1.35 (s, 3H, CH3), 1.41 (s, 3H, CH3), 1.43
(s, 6H, 2 CH3), 3.50 (dd, J 2.5 and 6.6 Hz, 1H, H-4), 3.60
(dd, J 4.2 and 12.0 Hz,1H, H-1), 3.81 (dd, J 12.0 and 3.6Hz,
1H, H-1’), 4.00-4.20 (5H, m, H-2, H-3, H-5, H-6, H-6’).
13C NMR (CDCl3) δ: 25.1, 26.6, 26.8, 27.1, 61.9, 66.9,
70.7, 76.3, 77.1, 77.4, 109.4, 109.5.
2,3:5,6-di-O-isopropylidene-1-p-toluenesulfonyl-D-
glucitol (5a) and 2,3:5,6-di-O-isopropylidene-1,4-di-p-
toluenesulfonyl-D-glucitol (5b)
Method A. To a solution of diacetonide 3 (1.45 g, 5.5
mmol) in Et3N (5.0 cm3) cooled externally by an ice bath
TsCl was added (1.43 g) under argon. The mixture was
stirred at 0 oC for 6 h and left to stand at room temperature
for 14 h. The mixture was dissolved in CH2Cl2 and the
solution was washed with saturated aqueous NaCl, dried
over anhydrous Na2SO4 and evaporated. The residue was
purified by column chromatography (6:4 heptane-EtOAc)
to give 5a (1.03 g, 45%), a monotosyl derivative and the
ditosyl 5b (1.09 g, 35%).
Method B. In a procedure similar to the one described
above, a mixture containing 3 (0.60 g, 2.29 mmol), CH2Cl2
(3.0 cm3), and Et3N (0.3 cm3) was added to TsCl (0.43 g),
under an inert atmosphere while being cooled externally
by an ice bath. The reaction was then kept in the refrigerator
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for 14 h. The mixture was dissolved in CH2Cl2 and the
resulting solution was washed with saturated aqueous
NaCl, dried (Na2SO4) and evaporated. The residue was
purified by column chromatography (6:4 heptane-EtOAc)
to give 5a (0.60 g, 63%), 5b (0.07 g, 2%) and 3 (0.15 g,
10%).
5a. Colourless oil; ν
max.
/cm-1: 3512, 1371, 1170, 1070,
737 (film); 1H NMR (CDCl3) δ: 1.39 (s, 6H, CH3), 1.33 (s,
3H, CH3), 1.35 (s, 3H, CH3), 2.43 (s, 3H, CH3), 2.28 (br, d,
1H, OH), 3.45 (t, J 3.0 and 7.6 Hz, 1H, H-4); 3.9-4.3 (m, 7H,
H-1, H-1’, H-2, H-3, H-5, H-6 and H-6’), 7.38 (d, J 8.4 Hz,
2H); 7.81 (d, J 8.4 Hz, 2H); 13C NMR (CDCl3) δ: 21.7, 25.3,
26.8, 26.9, 27.0, 67.2, 69.1, 71.3, 74.7, 76.3, 77.9, 109.8,
110.4, 128.3, 130.1, 132.1, 145.3.
5b. White amorphous solid; [α]D25= +7.9° found
(CHCl3); (lit.24,25 +6.8°). 1H NMR (CDCl3) δ 1.30 (s, 3H,
CH3), 1.35 (s, 6H, CH3), 1.39 (s, 3H, CH3), 2.45 (s, 3H, CH3),
2.46 (s, 3H, CH3), 3.81 (t, J 7.5 Hz, 1H, H-6), 3.95 (dd, J 3.8
and 7.5Hz, 2 H, H-4 and H-6’), 4.06-4.11 (m, 3H, H-1’, H-3
and H-5), 4.25 (dd, J 11.4 and 2.3Hz, 1H, H-1), 4.65-4.72
(m, 1H, H-2), 7.72 (d, 4H), 7.35 (m, 4H). 13C NMR (CDCl3)
δ: 21.6, 21.7, 25.6, 26.0, 26.8, 27.0, 65.7, 67.8, 74.1, 74.9,
78.7, 78.8, 109.7, 110.8, 127.9, 128.0, 129.8, 129.9, 132.1,
133.0, 145.1, 145.5.
4-Acetyl-2,3:5,6-di-O-isopropylidene-1-p-toluenesulfonyl-
D-glucitol (6)
To a mixture containing monotosyl derivative 5a (1.60
g, 3.85 mmol) and 10.0 cm3 of Et3N, 1.0 cm3 of acetic
anhydride was added. The mixture was stirred at room
temperature for 24 h. After that, it was neutralised with
aqueous NH3 and evaporated. The residue was dissolved
in CH2Cl2 and the solution was washed with saturated
aqueous NaCl and dried over Na2SO4. The Et3N was
evaporated in a rotary evaporator using MeOH for the
azeotropic system. Purification by a flash silica gel
chromatographic column (7:3 heptane-EtOAc) gave 6
(1.34 g, 76%). ν
max.
/cm-1: 2988; 1745; 1371; 1226; 1117
(film).
4-O-acetyl-1-azido-1-deoxy-2,3:5,6 di-O-isopropylidene-
D-glucitol (7)
To a mixture containing 4.21 g (9.2 mmol) of acetyl-
tosyl 6, 10.0 cm3 DMF and 2.0 cm3 H2O, 0.830 g NaN3
(12.7 mmol) was added. The mixture was heated under
reflux for 12 h. The solution was added to an ice-water
mixture. The precipitate formed was filtered and washed
with CH2Cl2. Purification by a flash silica gel
chromatographic column (7:3 heptane-EtOAc) gave 7
(2.68 g, 86%) as an amorphous compound, white solid.
ν
max.
/cm-1: 2988; 2104, 1740, 1372, 1225, 1070 (film). 1H
NMR (CDCl3) δ: 1.34 (s, 3H, CH3), 1.38 (s, 6H, CH3), 1.44
(s, 3H, CH3), 2.12 (s, 3H, CH3), 3.29 (dd, 1H, J 5.4 and 12.9
Hz, H-1), 3.59 ( dd, J 12.9 and 4.3 Hz, 1H, H-1’), 3.82-3.90
(m, 1H, H-2), 3.88 (dd, J 8.6 and 12.8 Hz,1H, H-6), 4.04
(dd, J 6.4 and 8.6 Hz, 1H, H-6), 4.13 (dd, J 2.1 and 7.5
Hz,1H, H-3), 4.26 (q, J 6.4 Hz,1H, H-5), 5.02 (dd, J 2.1 and
6.4 Hz, 1H, H-4). 13C NMR (CDCl3) δ: 20.8, 25.3, 26.5,
27.0, 51.1, 66.1, 70.4, 74.9, 75.7, 76.8, 109.5, 110.0, 170.3.
6-O-acetyl-1-azido-2,3-O-isopropylidene-D-glucitol (8a)
Method A. To a mixture containing acetyl azide 7
(1.10 g, 3.36 mmol) and MeOH (5.0 cm3), TsOH (catalyst,
0.1 mmol) was added. The mixture was stirred at 0 oC for
5 h, neutralised with aqueous NH3 (10% v/v) and
evaporated. The residue was dissolved in CH2Cl2, washed
with aqueous NaCl and dried over anhydrous Na2SO4.
Filtration and evaporation of the solvent gave a residue
that was purified on a chromatography column (1:1
heptane-EtOAc) giving 8a (0.33 g, 34%) and 7 (0.56 g,
51%). 1H NMR (CDCl3) δ: 1.45 (s, 3H, CH3), 1.48 (s,
3H,CH3), 2.11 (s, 3H, CH3), 2.64 (s, 1H, OH), 2.82 (d, 1H, J
4.8 Hz, OH), 3.35 (dd, 1H, J 5.0 and 13.2Hz, H-1), 3.49 (t,
1H, H-4), 3.57 (dd, 1H, J
 
4.1 Hz, H-1’), 3.84 (br, s, 1H, H-5),
4.2-4.3 (m, 1H, H-2), 4.19 (dd, J 2.2 and 7.9 Hz, 1H, H-3),
4.25 (dd, J 5.5 and 12.3 Hz, 1H, H-6), 4.43 (dd, J 2.7 and
12.3 Hz, 1H, H-6’); 1H NMR (CDCl3/D2O) δ: 1.45 (s, 3H,
CH3), 1.48 (s, 3H, CH3), 2.11 (s, 3H, CH3), 3.35 (dd, J 5.0
and 13.2Hz, 1H, H-1), 3.49 (dd, J 2.2 and 7.9 Hz, 1H, H-4),
3.57 (dd, J 4.0 and 13.2 Hz, 1H, H-1’), 4.20-4.30 (m, 1H, H-
2), 4.19 (dd, J 2.2 and 7.9 Hz, 1H, H-3), 4.25 (dd, J 5.5 and
12.3 Hz, 1H, H-6), 4.43 (dd, 2.7 and12.3 Hz,1H, H-6’); 13C
NMR (CDCl3) δ: 20.8, 26.9, 51.5, 66.21, 68.9, 71.8, 75.9,
76.6, 110.1, 171.7.
Method B. To a mixture containing 7 (0.53 g,
1.62 mmol) and MeOH (5.0 cm3), 4-pyridinium toluene-
sulfonate (0.05g) was added. The mixture was stirred at
room temperature for 12 h. Then, it was heated at 50 oC.
The reaction was stopped when TLC indicated the
presence of a third compound. The solution was neutralised
with aqueous NH3 (10% v/v) then purified using a silica
gel chromatographic column (1:1 heptane-EtOAc) giving
8a (0.02g, 4%), 8b (0.13g, 28%) and 7 (0.20g, 38%).
4-O-acetyl-1-azido-2,3-isopropylidene-D-glucitol (8b)
Colourless oil; 1H NMR (CDCl3): δ 1.38 (s, 3H, CH3),
1.42 (s, 3H, CH3), 2.10 (s, 3H, CH3), 3.29 (dd, J 13.3 and 5.0
Hz, 2H, H-1, H-6), 3.55 (dd, J 13.3 and 7Hz, 2H, H-1’,
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H-6’), 3.63 (br, s, 2H, 2 OH), 3.8-3.9 (m, 2H, H-2 and H-5),
4.29 (dd, J 8.2 and 2.2 Hz, 1H, H-3), 4.88 (dd, J 8.0 and 2.3
Hz, 1H, H-4). 1H NMR (CDCl3 /D2O) δ:1.42 (s, 3H, CH3),
1.38 (s, 3H, CH3), 2.10 (s, 3H, CH3), 3.34 (dd, J 13.2 and
5.1Hz, 1H, H-1), 3.53 (dd, J 12.0 and 5.1 Hz, 2H, H-6’),
3.60 (dd, J 13.2 and 3.5 Hz, 1H, H-1’), 3.69 (dd, J 12.0 and
3.2Hz, 1H, H-6’), 3.82-3.99 (m, 2H, H-2 and H-5), 4.33 (dd,
1H, J 8.3 and 2.2Hz, H-3), 4.91 (dd, 1H, J 8.1 and 2.1 Hz,
H-4). 13C NMR (CDCl3) δ: 21.4, 27.2, 27.6, 51.8, 63.4,
70.6, 71.2, 76.2, 77.0, 110.6, 171.7.
6-O-acetyl-1-azido-1-deoxy-2,3-isopropylidene-5-p-
toluenesulfonyl-D-glucitol (9a) and 6-O-acetyl-1-azido-
1-deoxy-2,3-isopropylidene-5,6-di-p-toluenesulfonyl-D-
glucitol (9b)
To a mixture containing acetyl azide 8 (0.25 g,
0.87 mmol) and 5.0 cm3 of Et3N, under an inert atmosphere,
cooled externally by an ice bath, TsCl (0.486g, mmol) was
added. The reaction was kept in the refrigerator for 12 h.
The filtrate was evaporated under reduced pressure to give
crude 9a and 9b that were purified by a silica gel
chromatographic column, (7:3 heptane-EtOAc) to yield
9a (0.14 g, 36%) and 9b (0.10 g, 19%).
9a. 1H NMR (CDCl3) δ: 1.33 (s, 3H, CH3), 1.39 (s, 3H,
CH3), 2.01 (s, 3H, CH3), 2.45 (s, 3H, CH3), 2.66, (d, J 9.8 Hz,
1H, -OH), 3.24 (dd, J 13.3 and 4.4 Hz, 1H, H-1), 3.54 (dd, J
13.3 and 4.0 Hz, 1H, H-1’), 3.62 (t, J 9.4, 1.0 Hz, 1H, H-4),
3.86 (dd, 1H, J 8.3 and 1.1 Hz, H-3), 4.10-4.16 (m, 1H,
H-2), 4.32 (dd, J 12.7 and 2.5 Hz, 1H, H-6), 4.50 (dd, J 12.7
and 5.1 Hz, 1H, H-6’), 4.66-4.74 (m, 1H, H-5), 7.32 (d, J
8.1Hz, 2H,), 7.82 (d, J 8.1Hz, 2H,). 13C NMR (CDCl3) δ:
20.9, 21.7, 27.0, 26.8, 50.9, 62.5, 67.0, 75.6, 75.7, 79.0,
111.8, 129.3, 131.3, 144.3, 167.8.
4,5-anhydro-1-azido-1-deoxy-2,3-isopropylidene-D-
glucitol (10)
To a mixture containing the tosyl azide 9a (0.10 g,
0.22 mmol) and 5.0 cm3 of MeOH, K2CO3 (0.114 g, 0.82
mmol) was added. The solution was stirred at room
temperature for 1 h. The residue was purified by TLC, (1:1
heptane-EtOAc), giving compound 10 (0.029 g, 58%) as a
colorless viscous oil. ν
max.
/cm-1: 3425; 2107, 1H NMR
(CDCl3) δ: 1.42 (s, 3H, CH3), 1.45 (s, 3H, CH3), 2.00 (br, 1H,
OH), 3.15 (dd, J 2.2 and 4.5 Hz, 1H, H-4), 3.25 (m, 1H, H-
5), 3.39 (dd, J 4.5 and 13.1 Hz, 1H, H-1), 3.59 (dd, J 4.5 and
13.1 Hz, 1H, H-1’), 3.71 (br, d, J 3 and 13 Hz, 1H, H-6), 3.92
(dd, J 2.2 and 4.5 Hz, 1H, H-3), 3.96 (dd, J 2.4 and 13.1Hz,
1H, H-6’), 4.10-4.18 (m, 1H, H-2). 13C NMR (CDCl3) δ:
26.6, 26.9, 51.5, 53.8, 55.6, 60.6, 77.5, 77.3, 110.6.
4,5-anhydro-1-azido-1-deoxy-2,3-isopropylidene-6-silyl-
D-glucitol (11)
To a mixture containing 0.025 g (0.11 mmol) of
epoxide 10 in 2.0 cm3 of DMF, tert-butyldimethylsilyl
chloride (0.032 g, 0.212 mmol) and imidazole (0.02 g,
0.34 mmol) were added under an inert atmosphere. The
solution was stirred at room temperature for 24 h. CH2Cl2
was added to the residue, and it was washed with an
aqueous solution of NaCl and dried over anhydrous
Na2SO4. Then, the solvent was removed under reduced
pressure. The residue was purified by PLC (6:4 heptane-
EtOAc), giving 11 (0.02 mg, 53%) and 10 (0.010 g, 42%).
1H NMR (CDCl3) δ: 0.06 (s, 3H, CH3), 0.07 (s, 3H, CH3),
0.89 (s, 9H, CH3), 1.42 (s, 3H, CH3), 1.45 (s, 3H, CH3), 3.00
(dd, J 2.2 and 4.7 Hz, 1H, H-4), 3.09-3.14 (m, 1H, H-5),
3.35 (dd, J 4.6 and 13.2 Hz, 1H), 3.58 (dd, J 4.2 and 13.2
Hz, 1H, H-1), 3.75 (dd, J 4.0 and 12.1 Hz, 1H, H-6’), 3.58
(dd, J 4.2 and 13.2 Hz, 1H, H-1’), 3.83 (dd, J 3.4 and 12.1
Hz, 1H, H-6), 3.88 (dd, 1H, J 4.7 and 8.1 Hz, H-3),
4.10-4.16 (m, 1H, H-2). 13C NMR (CDCl3) δ: -5.4, 18.3,
25.8, 26.6, 26.8, 51.5, 54.2, 55.7, 62.3, 76.6, 77.3, 110.5
1,5-dideoxy-1,5-imino-2,3-O-isopropylidene-D-glucitol
(13)
To a solution of 0.02 g of epoxide 11 (0.057 mmol) in
5.0 cm3 of EtOH, NaBH4 was added (0.002 g). The reaction
was stirred at room temperature for 12 h. As no reaction
was observed, the mixture was heated to 40 °C. After 24 h
of reaction, more NaBH4 (0.003 g) was added and the
solution was stirred at 40 °C for next 12 h. CH2Cl2 was
added to the mixture, which was then washed with aqueous
NaCl, dried over anhydrous Na2SO4 and the solvent was
removed under reduced pressure.
The residue was purified by TLC (1:1 heptane-EtOAc),
affording 13 (0.008 g, 48%). [α]D25= +23.6 (CHCl3); (lit.12
+20.1 (CHCl3)); 1H NMR (CDCl3) δ 0.08 (s, 3H, CH3 -Si),
0.10 (s, 3H, CH3-Si), 0.91 (s, 9H, CH3 (t-butyl-Si-), 1.47 (s,
6H, 2 CH3), 2.48-2.58 (m, 1H, H-5), 2.75 (dd, J 11.2 and
12.7 Hz, 1H, H-1
ax
), 3.28-3.36 (m, 2H, H-1’and H-2), 3.42
(t, J 8.7 Hz, 1H, H-3), 3.72 (t, J 8.7 Hz, 1H, H-4), 3.79 (dd,
J 4.7 and 9.8 Hz, 1H,H-6), 3.91 (dd, J 4.2 and 9.8 Hz, 1H,
H-6’).13C NMR (CDCl3) δ: -5.5, 18.2, 25.9, 26.3, 46.7, 60.8,
63.2, 72.0, 76.0, 84.2, 110.5. HR-EIMS m/z [M-CH3]+ found
302.167. Calc. for C14H28NO4Si: 302.179.
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